cromolyn sodium has been researched along with Invasiveness, Neoplasm in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Homan, T; Hoshino, T; Mima, S; Mizushima, T; Namba, T; Nishimura, T | 1 |
| Arumugam, T; Logsdon, CD; Ramachandran, V | 1 |
2 other study(ies) available for cromolyn sodium and Invasiveness, Neoplasm
| Article | Year |
|---|---|
Up-regulation of S100P expression by non-steroidal anti-inflammatory drugs and its role in anti-tumorigenic effects.
Topics: Activating Transcription Factor 4; Animals; Anti-Asthmatic Agents; Anti-Inflammatory Agents, Non-Steroidal; Apoptosis; Calcium-Binding Proteins; Celecoxib; Cell Line, Tumor; Consensus Sequence; Cromolyn Sodium; Endoplasmic Reticulum; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Proteins; Pyrazoles; Response Elements; Stomach Neoplasms; Sulfonamides; Up-Regulation | 2009 |
Effect of cromolyn on S100P interactions with RAGE and pancreatic cancer growth and invasion in mouse models.
Topics: Animals; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Line, Tumor; Chromatography, Affinity; Cromolyn Sodium; Deoxycytidine; Drug Synergism; Flow Cytometry; Gemcitabine; Gene Expression Regulation, Neoplastic; Genes, Reporter; Immunoprecipitation; Luciferases; Mice; Neoplasm Invasiveness; NF-kappa B; Pancreatic Neoplasms; Receptor for Advanced Glycation End Products; Receptors, Immunologic; S100 Proteins | 2006 |